What We Learned at ASAM2023What We Learned at ASAM2023
Addiction Medicine Journal Club
Drs. Del Tredici and Keenan share key takeaways from ASAM 2023, covering buprenorphine techniques, psilocybin potential, and COVID-19's impact on addiction.
41:02•8 May 2023
Key Takeaways from ASAM 2023: Innovations in Addiction Medicine
Episode Overview
- Insights into the impact of the ASAM conference and the latest research findings
- Exploration of advanced buprenorphine initiation techniques and their implications
- Discussion of the potential of psilocybin for alcohol use disorder
- Examination of the effects of COVID-19 on individuals with substance use disorder
- Insights into the evolving landscape of harm reduction and its significance
“Harm reduction is key for many people because abstinence is not possible or plausible. Sometimes abstinence is not desirable for our patients. Don't be afraid to try.”
Ever wondered what the latest buzz in addiction medicine is? Dr. Sonya Del Tredici and Dr. John Keenan bring you the highlights from the 2023 American Society of Addiction Medicine Conference. This episode of 'Addiction Medicine Journal Club' is packed with insights that could change how we approach addiction treatment. From advanced techniques in buprenorphine initiation to the groundbreaking potential of psilocybin for alcohol use disorder, there's a lot to unpack.
The hosts also discuss the lingering impact of COVID-19 on substance use disorders and evolving harm reduction strategies. Whether you're a healthcare professional or someone keen on the latest in addiction research, this episode offers a wealth of knowledge and thought-provoking discussions. Tune in to get a front-row seat to the future of addiction medicine.
Do you want to link to this podcast?
Get the buttons here!
More From This Show
The latest episodes from the same podcast.
Related Episodes
Similar episodes from other shows in the catalogue.